Examining the Truvada #BreakThePatent Debate: Gilead Responds
Top Research Reports for JPMorgan, Gilead Sciences & CSX
Gilead reports 3% revenue growth in Q1 2022
United States v. Gilead: The Fight for PrEP | Bill of Health
Gilead Sciences, Inc.
Gilead to Slice List Prices of Liver Drugs - WSJ
Generic HIV prevention drug coming in 2020, Gilead says
Trump administration sues Gilead over HIV drugs
PrEP's Still Too Costly For Many People At Risk For HIV : Shots - Health News : NPR
Single patient study adds to debate over Gilead's remdesivir for COVID-19 | Reuters
Gilead to launch generic versions of hepatitis C drugs | Modern Healthcare
Trump administration sues Gilead over HIV drugs
Gilead says generic Truvada will be available in 2020
Change to Gilead assistance program threatens PrEP access, HIV advocates say | PBS NewsHour
Gilead's COVID-19 antiviral Veklury blew past sales estimates in late 2021 as omicron surged, vaccinations lagged | Fierce Pharma
Gilead Advancing Access®: What to Know | Prism Health North Texas
Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine - Los Angeles Times
Gilead reaches multiyear agreement with White House to donate PrEP
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors | Fierce Pharma
Gilead to donate HIV prevention drug Truvada to 200K uninsured patients
Gilead's Biktarvy wins megablockbuster HIV nod, and rival GlaxoSmithKline strikes back | Fierce Pharma
FDA approves Gilead's multi-drug resistant HIV-1 treatment
Study: To be cost-effective, Gilead's new HIV pill needs near-50% price cut
Gilead Wins Key Patent Rights Suit Over PrEP Drugs for Preventing HIV - The New York Times
Gilead Will Donate Truvada to U.S. for H.I.V. Prevention - The New York Times
Gilead Assistance Programs For HIV, Hep B Drugs Will Dial Back Reimbursement To 340B Providers :: Pink Sheet
Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS
